Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fredriksson, K.
Right arrow Articles by Stromblad, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fredriksson, K.
Right arrow Articles by Stromblad, L. G.

Stroke, Vol 23, 972-977, Copyright © 1992 by American Heart Association


ARTICLES

Emergency reversal of anticoagulation after intracerebral hemorrhage

K Fredriksson, B Norrving and LG Stromblad
Department of Neurology, University Hospital, Lund, Sweden.

BACKGROUND AND PURPOSE: Although intracerebral hemorrhage is one of the most serious complications during oral anticoagulant therapy, there are no guidelines on emergency treatment with respect to reversal of anticoagulation effect in these patients. METHODS: We retrospectively compared laboratory data and clinical features in 17 cases of anticoagulant-related intracerebral hemorrhage treated with prothrombin complex concentrate (n = 10) or fresh-frozen plasma (n = 7). RESULTS: In the group of patients treated with prothrombin complex concentrate, the mean prothrombin time decreased from 2.83 to 1.22 International Normalized Ratio within 4.8 hours, compared with a decrease from 2.97 to 1.74 within 7.3 hours in those given fresh-frozen plasma (i.e., four to five times more rapidly after treatment with prothrombin complex concentrate) (p less than 0.001). Symptoms and signs of intracerebral hemorrhage, measured on an eight-graded Reaction Level Scale, progressed on average 0.2 grades in patients given prothrombin complex concentrate compared with 1.9 grades in those given fresh-frozen plasma (p less than 0.05). In patients with prothrombin values above 1.46, clinical progression within 12 hours occurred in five of six cases. CONCLUSIONS: Treatment with prothrombin complex concentrate reverses anticoagulation more rapidly than fresh-frozen plasma, which might be of importance for the prevention of further bleeding.


This article has been cited by other articles:


Home page
CirculationHome page
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al.
REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Circulation, October 16, 2007; 116(16): e391 - e413.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al.
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Stroke, June 1, 2007; 38(6): 2001 - 2023.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J. Dawson and M. Walters
New and emerging treatments for stroke
Br. Med. Bull., November 7, 2006; (2006) ldl011v1.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. B. Huttner, P. D. Schellinger, M. Hartmann, M. Kohrmann, E. Juettler, J. Wikner, S. Mueller, U. Meyding-Lamade, R. Strobl, U. Mansmann, et al.
Hematoma Growth and Outcome in Treated Neurocritical Care Patients With Intracerebral Hemorrhage Related to Oral Anticoagulant Therapy: Comparison of Acute Treatment Strategies Using Vitamin K, Fresh Frozen Plasma, and Prothrombin Complex Concentrates
Stroke, June 1, 2006; 37(6): 1465 - 1470.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Steiner, J. Rosand, and M. Diringer
Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions
Stroke, January 1, 2006; 37(1): 256 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
J P Hanley
Warfarin reversal
J. Clin. Pathol., November 1, 2004; 57(11): 1132 - 1139.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
M. A. Smythe, W. E. Dager, and N. M. Patel
Managing Complications of Anticoagulant Therapy
Journal of Pharmacy Practice, October 1, 2004; 17(5): 327 - 346.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
J. Rosand, M. H. Eckman, K. A. Knudsen, D. E. Singer, and S. M. Greenberg
The Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral Hemorrhage
Arch Intern Med, April 26, 2004; 164(8): 880 - 884.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. A. Mayer
Ultra-Early Hemostatic Therapy for Intracerebral Hemorrhage
Stroke, January 1, 2003; 34(1): 224 - 229.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Man-Son-Hing and A. Laupacis
Balancing the Risks of Stroke and Upper Gastrointestinal Tract Bleeding in Older Patients With Atrial Fibrillation
Arch Intern Med, March 11, 2002; 162(5): 541 - 550.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Sjoblom, H.-G. Hardemark, A. Lindgren, B. Norrving, M. Fahlen, M. Samuelsson, L. Stigendal, D. Stockelberg, A. Taghavi, L. Wallrup, et al.
Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study
Stroke, November 1, 2001; 32(11): 2567 - 2574.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F. Crawley, D. Bevan, and D. Wren
Management of intracranial bleeding associated with anticoagulation: balancing the risk of further bleeding against thromboembolism from prosthetic heart valves
J. Neurol. Neurosurg. Psychiatry, September 1, 2000; 69(3): 396 - 398.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
J. Berwaerts and J. Webster
Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages
QJM, August 1, 2000; 93(8): 513 - 521.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Man-Son-Hing, G. Nichol, A. Lau, and A. Laupacis
Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls
Arch Intern Med, April 12, 1999; 159(7): 677 - 685.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. G. Hart, B. S. Boop, and D. C. Anderson
Oral Anticoagulants and Intracranial Hemorrhage : Facts and Hypotheses
Stroke, August 1, 1995; 26(8): 1471 - 1477.
[Abstract] [Full Text]